Oncoinvent Asa

Oncoinvent Asa company information, Employees & Contact Information

Explore related pages

Related company profiles:

Oncoinvent is a clinical stage company committed to developing new innovative radiopharmaceutical products for better treatment options for cancer patients. Radspherin®, the company’s lead product candidate is a novel alpha-emitting radioactive microsphere suspension designed for treatment of metastatic cancers in body cavities. Radspherin® has shown strong and consistent anticancer activity at essentially non-toxic doses in preclinical studies and is anticipated to potentially treat several forms of metastatic cancer. Situated in Oslo, Oncoinvent’s main offices include modern laboratory facilities suitable for cGMP and radiopharmaceutical manufacture for clinical trials and research. The development programs of the company include radiotherapeutic and radioimmunotherapeutic products with focus on alpha-emitting radionuclides for treatment of various solid cancers.

Company Details

Employees
43
Founded
-
Address
Gullhaugveien 7, Oslo,oslo 0484,norway
Phone
4722183305
Email
kv****@****ent.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Oslo, Oslo
Looking for a particular Oncoinvent Asa employee's phone or email?

Oncoinvent Asa Questions

News

BerGenBio ASA: Approval and publication of prospectus - TradingView

BerGenBio ASA: Approval and publication of prospectus TradingView

BerGenBio ASA: Approval and publication of prospectus - TradingView

BerGenBio ASA: Approval and publication of prospectus TradingView

BerGenBio, in wake of lead cancer drug's failure, opts to merge with radiopharma Oncoinvent - Fierce Biotech

BerGenBio, in wake of lead cancer drug's failure, opts to merge with radiopharma Oncoinvent Fierce Biotech

BerGenBio and Oncoinvent - Key Dates for Completion of Merger - TradingView

BerGenBio and Oncoinvent - Key Dates for Completion of Merger TradingView

Oncoinvent Announces Agreement with ARTBIO to Collaborate on Radiopharma Laboratory Facilities - Business Wire

Oncoinvent Announces Agreement with ARTBIO to Collaborate on Radiopharma Laboratory Facilities Business Wire

Oncoinvent reports promising results for cancer treatment Radspherin - Investing.com

Oncoinvent reports promising results for cancer treatment Radspherin Investing.com

Oncoinvent doses first subject in Phase II ovarian cancer treatment trial - Clinical Trials Arena

Oncoinvent doses first subject in Phase II ovarian cancer treatment trial Clinical Trials Arena

Valuation Update: What insider purchases suggest about Oncoinvent ASA (9Y8) stock - Bear Alert & Advanced Swing Trade Entry Alerts - Trung tâm Dự báo KTTV quốc gia

Valuation Update: What insider purchases suggest about Oncoinvent ASA (9Y8) stock - Bear Alert & Advanced Swing Trade Entry Alerts Trung tâm Dự báo KTTV quốc gia

FDA Grants Fast Track Designation to Radspherin for Peritoneal Carcinomatosis From Ovarian Cancer - OncLive

FDA Grants Fast Track Designation to Radspherin for Peritoneal Carcinomatosis From Ovarian Cancer OncLive

Oncoinvent strengthens board and cash position - Biostock

Oncoinvent strengthens board and cash position Biostock

Can Oncoinvent ASA (9Y8) stock deliver double digit returns - Market Risk Report & Fast Gain Swing Trade Alerts - Trung tâm Dự báo KTTV quốc gia

Can Oncoinvent ASA (9Y8) stock deliver double digit returns - Market Risk Report & Fast Gain Swing Trade Alerts Trung tâm Dự báo KTTV quốc gia

How strong dollar benefits Oncoinvent ASA (9Y8) stock - Dividend Hike & Verified Technical Signals - Trung tâm Dự báo KTTV quốc gia

How strong dollar benefits Oncoinvent ASA (9Y8) stock - Dividend Hike & Verified Technical Signals Trung tâm Dự báo KTTV quốc gia

BerGenBio and Oncoinvent - Key Dates for Completion of Merger - TradingView

BerGenBio and Oncoinvent - Key Dates for Completion of Merger TradingView

Market Catalysts: How strong dollar benefits Oncoinvent ASA (9Y8) stock - 2025 Price Action Summary & Daily Profit Maximizing Trade Tips - Trung tâm Dự báo KTTV quốc gia

Market Catalysts: How strong dollar benefits Oncoinvent ASA (9Y8) stock - 2025 Price Action Summary & Daily Profit Maximizing Trade Tips Trung tâm Dự báo KTTV quốc gia

Top Oncoinvent Asa Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant